An Open-Label, Crossover Study to Assess the Effect of Food on the Oral Bioavailability and Pharmacokinetic Profile of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects

• Status: Completed
• Trial end date: 1969-12-31

Summary

To characterize the pharmacokinetics of orally administered FLT (in a liquid formulation) after single doses in both the fed and fasting states; to assess the effect of food on the oral bioavailability of FLT

• Phase: N/A

Details

• Lead Sponsor: Lederle Laboratories
• Treatments: Alovudine; Dideoxynucleosides